Original document(20 pages) Authorized document(20 pages) 中文版
    The present invention relates to one kind of folic acid-polysaccharide composite, specially folic acid-dextran composite and its preparation as well as composite medicine with the composite as active component and the application of the composite medicine in treating tumor. The folic acid-polysaccharide has an general expression of X-Y, where X is folic acid, its derivative or some matter capable of entering cell via folic acid acceptor in cell membrane, and Y is various polysaccharide.
Application Number
申请号		 00115752 Application Date
申请日		 2000.05.18
Title 名称 Folica acid-polysaccharide composite and its preparation and medical composition with the composite as active component
Publication Number
公开号		 1287127 Publication Date
公开日		 2001.03.14
Approval Pub. Date Granted Pub. Date 2002.12.04
International Classification 分类号 A61K31/716,A61P35/04,C08B37/02
Applicant(s) Name
申请人		 Shanghai Medical Univ.
Address 地址 200032
Inventor(s) Name 发明人 Lu Weiyue, Liu Min
Attorney & Agent 代理人 wu guiqin

  
Folic acid-polydiol compound and its medicinal composition
Long-acting injection capable of inhibiting abrupt release effect
Method for producing bio-adhered micro-ball medicine preparation for gastrointestinal tract
Method for stablizing protein medicine and its application in microball preparation
Temperature sensitive gel formulation for in situ vagina uses
Method for promoting liposome lymph absorption and reducing normal lymph node accumulation
Cyclic peptide containing arginine, glycine, asparagicacid-sequence and active target liposome
Liposome administration system with tumor necrosis targeted antibody for preposition and application thereof
Loquat polysaccharide extracting process
Method of extracting immune globulin A from milk
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.